News | RIVM

Grey heron infected with West Nile virus

A grey heron in the Noord-Holland-Noord region has tested positive for the West Nile virus. The virus is rare in the Netherlands.

Bas van de Meulengraaf

Side effect reports National Immunisation Programme 2021

Last year, the Netherlands Pharmacovigilance Centre Lareb received 1,462 reports of possible side effects from vaccines administered under the National Immunisation Programme. As was the case in previous years, no new, disconcerting side effects have

Participation in National Immunisation Programme shows slight decrease

Participation in the National Immunisation Programme has fallen slightly, showing a decrease of 1 to 2 percentage points.

RIVM expands HPV vaccination programme: girls and boys protected from six types of cancer with one vaccine

Now not only girls, but also boys will have the opportunity to protect themselves from cancer caused by HPV.

Jongen en meisjes poseren op een kruk voor campagneposter HPV vaccin

The National Immunisation Programme: the number of disease notifications decreased substantially in 2020

In 2020, fewer people fell ill from a disease against which vaccination is included in the National Immunisation Programme than in 2019. This is most likely due to coronavirus measures, such as social distancing, handwashing, and travel restrictions.

Vaccination coverage increases for second consecutive year, by 10% for HPV

The percentage of children receiving vaccinations from the National Immunisation Programme rose again last year. Another striking note is the 10% increase in HPV vaccination, rising to 63%.

Het aantal jonge vrouwen dat zich laat vaccineren tegen HPV is toegenomen met 10%

New WHO protocol for integrated One Health surveillance of antibiotic resistance: the Tricycle protocol

The World Health Organization (WHO) has developed a protocol for global One Health surveillance of antimicrobial resistance based on one indicator, Extended Spectrum Beta-Lactamase producing E.

Tricycle protocol global One Health Surveillance

WHO

Report on the developments of the National Immunisation Programme: national immunisation coverage increased slightly for the first time in five years

National immunisation coverage has increased for the first time in five years, for almost all vaccinations. For children born in 2017, vaccination coverage against mumps, measles and rubella (MMR) increased by 0.7% to 93.6%.

Corona crisis has limited impact on infant participation in National Immunisation Programme

Nearly all infants in the Netherlands are still participating in the National Immunisation Programme.

More children vaccinated against mumps, measles, rubella and HPV

The percentage of newborns participating in the immunisation programme targeting mumps, measles and rubella rose slightly over the past year.